Establishing secure connection…Loading editor…Preparing document…

FDA Information Document

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

FDA INFORMATION DOCUMENT

Parties

Effective Date:

Recitals

WHEREAS, Disclosing Party possesses certain regulatory, technical, clinical and commercial information relating to medical device technology identified as Device Name: (the "Device"), which may be relevant to regulatory submissions and compliance requirements; and

WHEREAS, Receiving Party requires access to such information for purposes of regulatory strategy, submission preparation, testing coordination, or other authorized activities described herein; and

WHEREAS, the parties desire to set forth the scope, terms of exchange, confidentiality, payment and governing law provisions applicable to the information exchanged under this Document.

Scope of Work

Regulatory Information

Intended Use / Indications for Use:

Regulatory Pathway (select all that apply):

Payment Terms

Late Payment: If payment is not received within days of the invoice due date, interest shall accrue at of the outstanding balance, and the Disclosing Party may suspend deliverables until payments are current.

Term and Termination

Term Commencement Date: and Termination Date: , unless earlier terminated as provided herein.

Either party may terminate this Document for material breach by the other party if the breaching party fails to cure such breach within days after receipt of written notice. Either party may terminate for convenience upon days' prior written notice to the other party.

Confidentiality

All non-public information disclosed by either party in connection with this Document, whether oral or written and designated as confidential or that reasonably should be understood to be confidential given its nature ("Confidential Information"), shall be held in strict confidence. Receiving Party shall not disclose, publish, or disseminate Confidential Information to any third party except to its employees, consultants or contractors with a need to know and who are bound to confidentiality obligations at least as protective as those herein. Receiving Party shall use Confidential Information solely for the purpose set forth in the Scope of Work. Exceptions include information that (a) is or becomes publicly available through no breach by Receiving Party; (b) is rightfully obtained by Receiving Party from a third party without restriction; (c) is independently developed without use of Confidential Information; or (d) must be disclosed by law or order, provided Receiving Party gives prompt written notice and cooperates in seeking protective measures.

Representations and Warranties

Each party represents that it has the full right and authority to enter into this Document and to perform its obligations hereunder. Disclosing Party represents that, to its knowledge, the information provided does not knowingly infringe third-party intellectual property rights. EXCEPT AS EXPRESSLY SET FORTH IN THIS DOCUMENT, ALL INFORMATION IS PROVIDED "AS IS" WITHOUT WARRANTIES OF ANY KIND, AND NEITHER PARTY MAKES ANY WARRANTY AS TO THE SUITABILITY OF THE INFORMATION FOR REGULATORY APPROVAL OR BUSINESS PURPOSES.

Governing Law

This Document shall be governed by and construed in accordance with the laws of the State of without regard to conflicts of law principles.

Notices

Entire Agreement

This Document, including any appendices or attachments expressly incorporated herein, constitutes the entire agreement between the parties with respect to the subject matter and supersedes all prior and contemporaneous agreements, representations and understandings, whether written or oral. No amendment shall be effective unless in writing and signed by authorized representatives of both parties.

Data Handling and Record Retention

Records and data exchanged under this Document shall be retained for a period necessary to satisfy regulatory obligations and as otherwise required by applicable law, but in no event less than years following final delivery or termination. Each party shall implement reasonable administrative, physical, and technical safeguards to protect such data.

Disclosing Party Printed Name:

By:

Date:

Receiving Party Printed Name:

By:

Date:

Enter text✕
Prepare your document for signing right on this page
  • 01 Edit the text and complete the fields
  • 02 Click Sign Now and on the next screen add recipients and signature fields in SignNow
  • 03 Start your free trial to sign and send your doc
Sign Now

What the FDA Information Document Is and When It’s Used

The FDA Information Document is a structured record used to communicate regulated product details, safety data, regulatory status, or submission metadata to the U.S. Food and Drug Administration. It is commonly used as an administrative cover sheet, technical summary, or supporting attachment for premarket notifications, adverse event reports, and regulatory correspondence. The format and required content vary by submission type and regulatory program, but every FDA Information Document should clearly identify the product, the submitting party, relevant dates, and the regulatory context to which it applies, enabling reviewers to route and assess the enclosed materials efficiently.

Why a Clear FDA Information Document Matters

A clear FDA Information Document reduces review delays by providing consistent identifiers, contact details, and submission context. It helps ensure the receiving office assigns the record correctly and links it to related files without unnecessary follow-up.

Why a Clear FDA Information Document Matters

Who Typically Prepares and Reviews This Document

Teams involved in regulated-product filings prepare FDA Information Documents to support formal submissions, complaints, or regulatory updates.

  • Regulatory Affairs teams preparing submissions and correspondence for FDA review.
  • Quality and Compliance staff documenting adverse events, recalls, or corrective actions.
  • Legal and corporate affairs professionals coordinating responses to FDA inquiries.

The document is also reviewed by FDA intake officers and program-specific reviewers who rely on accurate metadata to process and link records efficiently.

Core Elements Every Professional FDA Information Document Should Include

A professional document follows a consistent structure that helps both sender and FDA staff find critical facts quickly and reduces the likelihood of processing errors.

Document Title

A concise title stating the submission type and brief subject matter, enabling rapid identification in intake logs and reviewer queues.

Submitting Party

Legal entity name, point of contact with email and phone, and physical address so FDA can request clarification or serve notices without delay.

Product Identification

Clear product name, model or lot numbers, catalog numbers, and any FDA-assigned identifiers to ensure linkage to existing records.

Regulatory Context

Specify the submission pathway or program (e.g., 510(k), PMA supplement, MDR, 513(g)), so the document is routed correctly.

Summary of Contents

One-paragraph overview of attachments and the purpose of the submission to help reviewers prioritize and triage materials.

Date and Signatures

Effective date and authorized signer details; include electronic signature metadata where applicable to prove execution.

Required Information Fields at a Glance

Title: Document title
Submitter: Entity name
Contact: Name and phone
Product ID: Model/lot/UDI
Submission Type: 510(k)/PMA/MDR/etc.
Effective Date: MM/DD/YYYY

Stepwise Process to Complete an FDA Information Document

Follow these sequential steps to assemble and verify the document before submission to minimize intake issues and review delays.

  • 01
    Gather Identifiers: Collect product IDs and prior submission numbers.
  • 02
    Confirm Submitter: Verify legal entity and contact details.
  • 03
    Draft Summary: Write a one-paragraph overview of attachments and purpose.
  • 04
    Validate Date & Sign: Set effective date and obtain authorized signature.

How to Configure an Online Workflow for This Document

An online workflow enforces required fields and captures audit data to meet FDA traceability expectations and support electronic submissions.

Field Configuration
Required Fields Make title, submitter, and product ID mandatory
Signature Field Capture signer name, role, and date
Authentication Enable email or SMS code for signer verification
Audit Trail Record IP, timestamp, and actions

Where to Send or File the FDA Information Document

Route the document to the program office or submission portal that handles the related filing type; routing depends on the submission pathway and FDA center.

  • Electronic Submissions Gateway: Use ESG for structured eSubmissions when required
  • Center-Specific Portals: Submit via CDRH, CDER, or CBER portals as applicable
  • MDRs and Reports: File medical device reports in the MDR system
  • Paper Correspondence: Mail to the appropriate FDA docket or office address

Technical Requirements for Digital Signing and eSubmission

Digital delivery and eSignature tools must capture signer identity, version history, and an immutable audit trail to support regulatory review.

  • File Formats: PDF/A preferred
  • Signature Evidence: Audit trail with timestamps
  • Authentication: Email, SMS, or stronger

Use platforms that support required export formats, tamper-evident PDFs, and secure storage to meet FDA intake and traceability expectations.

Key Deadlines and Timing Considerations

Different submission types have distinct timing rules; track applicable deadlines tied to event occurrence, reporting windows, and statutory timelines.

Adverse Event Reporting:

Follow FDA program timelines (e.g., MDR deadlines for devices)

Quarterly Reports:

Submit as scheduled per program requirements

PMA/510(k) Supplements:

Meet submission windows defined by regulatory pathway

Meeting Requests:

Allow sufficient lead time for scheduling

Responding to FDA:

Respond promptly to avoid enforcement or review delays

Common Preparation Errors to Avoid

  • Incomplete product identifiers that prevent linkage to prior submissions and cause intake clerks to request clarifying information.
  • Missing or incorrect submitter contact details that delay queries and extend review time due to unreachable points of contact.
  • Submitting the wrong regulatory pathway designation, which can reroute the filing and substantially lengthen review timelines.
  • Failing to attach required supporting files or using unsupported file formats that result in rejection by the submission portal.

Consequences of Incorrect or Late FDA Information Documents

Processing Delays: Extended review times
Rejection: Submission may be rejected
Regulatory Action: Possible warning letter
Fines: Civil penalties possible
Corrective Orders: May prompt recalls or holds
Reputation: Impacts regulatory credibility

Practical Examples from Organizations That Use Structured Submission Documents

Real-world examples illustrate how a concise information document supports regulatory interactions and speeds processing.

Xerox — Integration Example

Xerox automated submission metadata to link records across systems and avoid duplication.

  • This reduced manual intake tasks significantly.
  • The result was improved traceability between submissions and internal ERP records, enabling faster retrieval during regulatory audits and fewer follow-up requests from reviewers.

Martin Properties — Field Reporting

A property management firm standardized incident reports with a single information document template.

  • Field teams completed the template onsite for faster intake.
  • Standardization improved routing accuracy to the correct agency contact and reduced time-to-resolution on compliance matters.

Practical Tips for Accurate and Efficient Completion

Apply consistent naming, validation checks, and version control to reduce errors and streamline review.

Use Standard Templates
Create and maintain a validated template that enforces required fields, reducing reliance on manual formatting and preventing missing data.
Validate Identifiers
Cross-check model numbers, lot codes, and UDIs against labels and prior filings to avoid mismatches that trigger intake queries.
Capture Audit Data
Ensure the platform records signer identity, timestamps, and IP addresses to provide traceability for regulatory review.
Preflight Review
Have a second reviewer confirm attachments and routing to catch omissions before submission to FDA.

eSignature Vendor Comparison for FDA Information Document Workflows

Compare common vendor pricing and feature indicators relevant to secure signing, HIPAA needs, and envelope limits for high-volume regulatory workflows.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies by plan Varies by plan Varies by plan Varies by plan
Bulk Send Yes (Business Premium) Varies by plan Varies by plan Varies by plan Varies by plan
Audit Trail Yes Yes Yes Yes Yes
Envelope Cap No cap 100 envelopes/user/year Varies Varies Varies

Frequently Asked Questions About FDA Information Documents

Answers to common questions about signing, submission format, legal validity, and retention of FDA Information Documents.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users
Sign Now
Company
Forms
Pricing
Resources
Knowledge base
Other Products
© 2026 airSlate Inc. All rights reserved.